Anna Malashicheva News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anna malashicheva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anna Malashicheva Today - Breaking & Trending Today

New Drug Candidate Holds Potential in Treating Heart Disease

New Drug Candidate Holds Potential in Treating Heart Disease
by Angela Mohan on
December 11, 2020 at 10:29 AM
Science by scientists from Gladstone Institute.
Calcific aortic valve disease is not only the most common valve disease in the elderly, it s also the third leading cause of heart disease overall. For those affected, calcium starts to accumulate in their heart valves and vessels over time, until they harden like bone.
As a result, blood flow out of the heart s pumping chamber to the body gets obstructed, leading to heart failure. Yet no medical therapy currently exists. All patients can do is wait for the calcification (or hardening) to become bad enough that they need surgery to replace their valve. ....

United States , Catheterizationheart Attackair , Christinav Theodoris , Anna Malashicheva , Roddenberry Stem Cell Center Deepak Srivastava , Russian Academy Of Sciences , Gladstone Institute , Department Of Pediatrics , Gladstone President , Holistic Approach , Boston Children , Drug Candidate Rises , Russian Academy , Toxicityclinical Trials , Cardiac Catheterizationheart Attackair , Diet Lifestyle , ஒன்றுபட்டது மாநிலங்களில் , ரோடன் பெர்ரி தண்டு செல் மையம் தீபக் சிரிவாஸ்தவ , ரஷ்ய கலைக்கழகம் ஆஃப் அறிவியல் , மகிழ்ச்சியான கல் நிறுவனம் , துறை ஆஃப் குழந்தை மருத்துவம் , மகிழ்ச்சியான கல் ப்ரெஸிடெஂட் , முழுமையான அணுகுமுறை , போஸ்டன் குழந்தைகள் , மருந்து வேட்பாளர் உயர்கிறது , ரஷ்ய கலைக்கழகம் ,

A potential therapy for one of the leading causes of heart disease

E-Mail
SAN FRANCISCO, CA December 10, 2020 Calcific aortic valve disease is not only the most common valve disease in the elderly, it s also the third leading cause of heart disease overall. For those affected, calcium starts to accumulate in their heart valves and vessels over time, until they harden like bone. As a result, blood flow out of the heart s pumping chamber to the body gets obstructed, leading to heart failure. Yet no medical therapy currently exists. All patients can do is wait for the calcification (or hardening) to become bad enough that they need surgery to replace their valve.
After 15 years of unrelenting work, a team of scientists from Gladstone Institutes has now discovered a potential drug candidate for heart valve disease that works in both human cells and animals and is ready to move toward a clinical trial. Their findings were just published in the journal ....

United States , Saratovskaya Oblast , Yu Zhang , Yu Huang , Vladimir Uspensky , Sanjeevs Ranade , Tomohiro Nishino , Christinav Theodoris , Aleksandra Kostina , Caseya Gifford , Anna Malashicheva , Roddenberry Stem Cell Center Deepak Srivastava , Russian Academy Of Sciences , American Heart Association , National Center , Almazov Federal Medical Research Centre , Harvard Medical School , Roddenberry Foundation , Research Resources , Younger Family Fund , Department Of Pediatrics , California Institute Of Regenerative Medicine , Blood Institute , National Heart , Uehara Memorial Foundation , Lk Whittier Foundation ,